Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, once again, is quite modest. We plan to catch up on our reading, promenade with the official mascot and check in on the Pharmalot ancestors. And what about you? This is a fine time to hunt for apples and pumpkins. You could drop off your ballot or boost the economy by purchasing a few sweaters. Or make time to touch base with someone feeling isolated. Well, whatever you do, have a grand time. But be safe, wear a mask. Enjoy, and see you on Tuesday, due to a holiday break. …

President Trump and White House chief of staff Mark Meadows have urged Food and Drug Administration commissioner Stephen Hahn to accelerate agency reviews of antibody cocktails from Regeneron Pharmaceuticals (REGN) and Eli Lilly (LLY) for treating Covid-19, The Washington Post reports. Both drug makers have sought emergency use authorization from the FDA. Trump said the administration intends to make both treatments free for patients suffering from the virus, especially seniors.


Caught by surprise by President Trump’s promise to deliver drug-discount cards to seniors, health officials are scrambling to get the nearly $8 billion plan done by Election Day, according to Politico. The administration is seeking to finalize the taxpayer-funded plan as soon as Friday and send letters to 39 million Medicare beneficiaries next week, informing seniors of Trump’s new effort to lower their drug costs, although many seniors would not receive the actual cards until after the election.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!